亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Endovascular recanalization of chronically occluded internal carotid artery

医学 血管内治疗 颈内动脉 闭塞 血运重建 置信区间 外科 内科学 动脉瘤 心肌梗塞
作者
Fédérico Cagnazzo,Pierre-Henri Lefèvre,Imad Derraz,Cyril Dargazanli,Grégory Gascou,Carlos Riquelme,Raed Ahmed,Alain Bonafé,Vincent Costalat
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:12 (10): 946-951 被引量:39
标识
DOI:10.1136/neurintsurg-2019-015701
摘要

Background It is debated whether endovascular treatment is indicated for a symptomatic chronically occluded internal carotid artery (COICA). Objective To assess outcomes after endovascular treatment of COICA. Methods We performed a systematic search of three databases (PRISMA guidelines), including endovascular series of COICA. Outcomes were analyzed with random-effects models. Results We included 13 studies and 528 endovascularly treated patients with COICA. Successful recanalization was 72.6% (347/528, 95% CI 65.4% to 79.9%, I 2 =68.9%). Complications were 18% (88/516, 95% CI 12.1% to 23.8%, I 2 =65%), with 5% (25/480, 95% CI 2% to 7%, I 2 =0%) of permanent events, and 9% (43/516, 95% CI 6% to 13%, I 2 =34%) of thromboembolisms. Treatment-related mortality was 2% (11/516, 95% CI 0.5% to 2.6%, I 2 =0%). Shorter duration of the occlusion was associated with higher recanalization: 80% (11/516, 95% CI 54% to 89%, I 2 =0%), 63% (33/52, 95% CI 49% to 76%, I 2 =0%), and 51% (18/35, 95% CI to 37% to 88%, I 2 =40%) recanalization rates for 1, 3, and >3 months occlusions, respectively. Complications were 6% (3/50, 95% CI 3% to 21%, I 2 =0%), 14% (4/27, 95% CI 5% to 26%, I 2 =0%), and 25% (13/47, 95% CI 10% to 30%, I 2 =0%) for 1, 3, and >3 months occlusions, respectively. Patient aged <70 years presented higher revascularization rates (OR=3.1, 95% CI 1.2 to 10, I 2 =0%, p=0.05). Successful reperfusion was higher (OR=5.7, 95% CI 1.2 to 26, I 2 =60%, p=0.02) and complications were lower (OR=0.2, 95% CI 0.6 to 0.8, I 2 =0%, p=0.03) for lesions limited to the cervical internal carotid artery compared with the petrocavernous segment. Successful recanalization significantly lowered the rate of thromboembolisms (OR=0.2, 95% CI 0.8 to 0.6, I 2 =0%, p=0.01) and mortality (OR=0.5, 95% CI 0.1 to 0.9, I 2 =0%, p=0.04), compared with conservative treatment. Conclusions Endovascular treatment of COICA gives a 70% rate of successful recanalization, with 5% morbidity. Patients aged <70 years, lesions limited to the cervical internal carotid artery, and a shorter duration of the occlusion decreased the risk of complications. Successful recanalization of symptomatic lesions lowered by about 80% the likelihood of thromboembolisms, compared with medical management.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yyy发布了新的文献求助10
2秒前
3秒前
7秒前
10秒前
11秒前
西湖醋鱼完成签到,获得积分10
12秒前
12秒前
淡淡元蝶完成签到 ,获得积分10
13秒前
大黄蜂发布了新的文献求助30
14秒前
beifa发布了新的文献求助10
17秒前
22秒前
占囧发布了新的文献求助10
27秒前
slby完成签到 ,获得积分10
32秒前
科研通AI6.1应助占囧采纳,获得10
37秒前
彧辰完成签到 ,获得积分10
39秒前
大黄蜂完成签到,获得积分10
39秒前
科研通AI2S应助yyy采纳,获得10
44秒前
cy完成签到,获得积分20
46秒前
KYT完成签到 ,获得积分10
46秒前
49秒前
科研通AI6.1应助cy采纳,获得30
50秒前
50秒前
50秒前
67n发布了新的文献求助10
53秒前
小蘑菇应助冷风寒采纳,获得10
53秒前
共享精神应助哈哈采纳,获得10
53秒前
SSY发布了新的文献求助10
54秒前
yyy发布了新的文献求助10
55秒前
56秒前
好人完成签到,获得积分10
57秒前
YJL发布了新的文献求助10
58秒前
59秒前
华仔应助shinn采纳,获得10
1分钟前
1分钟前
1分钟前
1分钟前
晴朗发布了新的文献求助10
1分钟前
占囧完成签到,获得积分10
1分钟前
beifa完成签到,获得积分10
1分钟前
所所应助wdw2501采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Agyptische Geschichte der 21.30. Dynastie 3000
Aerospace Engineering Education During the First Century of Flight 2000
„Semitische Wissenschaften“? 1510
从k到英国情人 1500
sQUIZ your knowledge: Multiple progressive erythematous plaques and nodules in an elderly man 1000
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5772365
求助须知:如何正确求助?哪些是违规求助? 5597951
关于积分的说明 15429577
捐赠科研通 4905375
什么是DOI,文献DOI怎么找? 2639348
邀请新用户注册赠送积分活动 1587287
关于科研通互助平台的介绍 1542124